| Autor: |
Escudier B; Institute Gustave Roussy, Villejuif, France. Electronic address: escudier@gustaveroussy.fr., Sharma P; MD Anderson Cancer Center, University of Texas, Houston, TX, USA., McDermott DF; Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA., George S; Roswell Park Cancer Institute, Buffalo, NY, USA., Hammers HJ; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Srinivas S; Stanford Cancer Institute, Stanford, CA, USA., Tykodi SS; University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Sosman JA; Vanderbilt University Medical Center, Nashville, TN, USA., Procopio G; Fondazione Istituto Nazionale Tumori, Milan, Italy., Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA., Castellano D; Hospital Universitario 12 De Octubre, Madrid, Spain., Gurney H; Westmead Hospital, Westmead, NSW, Australia., Donskov F; Aarhus University Hospital, Aarhus, Denmark., Peltola K; Comprehensive Cancer Center, Helsinki University Central Hospital Cancer Center, Helsinki, Finland., Wagstaff J; South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK., Gauler TC; University Hospital Essen of University of Duisburg-Essen, Essen, Germany., Ueda T; Chiba Cancer Center, Chiba, Japan., Zhao H; Bristol-Myers Squibb, Princeton, NJ, USA., Waxman IM; Bristol-Myers Squibb, Princeton, NJ, USA., Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA. |
Full Text from ScienceDirect